4Filing Date: Sep 3, 2026

Lab (LH)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000920148-26-000190
Total Value$0
Trades1
Insiders1

Transaction Details

Caveney Brian J
EVP, Pres of BLS, CMO & CSO·Direct
Grant · Acquire
Restricted Stock UnitDerivative
Shares+3.00K
Price$0.00
Total Value$0
Shares Owned After7.17K
Transaction DateSep 1, 2026
Footnotes ▸

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. | The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. | The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. | This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Post-Transaction Holdings

Caveney Brian J · EVP, Pres of BLS, CMO & CSO
SecuritySharesChange
Restricted Stock Unit7.17K+3.00K (71.94%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: LABCORP HOLDINGS INC. (LH) CIK: 0000920148 --- Reporting Owner --- Name: Caveney Brian J CIK: 0001717915 Role: Officer (EVP, Pres of BLS, CMO & CSO) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-09-01 | Code: A (Grant or award) Shares: +3,000 | Price: $0.00 Shares Owned After: 7,170 | Ownership: D (Direct) Footnotes: [F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. [F2] The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. [F2] The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. [F3] This number reflects the aggregate number of Restricted Stock Units held by the reporting person. --- Footnotes (Complete Index) --- F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2: The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. --- Signature --- /s/ /s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney (2026-09-03)

keid analysis is for reference only and does not constitute investment advice.